Germany

The divestment forms part of the company’s broader restructuring as it seeks to strengthen its finances and sharpen its focus on higher-value healthcare products.

BYPHAR is designed to simplify raw material selection while helping manufacturers meet increasingly stringent quality and regulatory requirements throughout the development and production process.

The partnership combines Budenheim’s manufacturing expertise with Brenntag’s biopharma services and distribution network.

External assessments have also recognized Syntegon’s sustainability performance, including an improved “B” rating from CDP for climate change and a ranking among the top 2 percent of companies assessed worldwide by EcoVadis.

The latest investment represents the next phase in the long-term development of the Kemnath site, which plays a significant role in the company’s manufacturing operations.

The agreement gives Apollo-managed funds and affiliates a non-controlling interest in a newly created entity that will hold Bayer’s LARC portfolio.

Unlike conventional sequencing technologies, Axelios 1 uses SBX chemistry to convert DNA or RNA molecules into enlarged surrogate polymers known as Xpandomers.

The collaboration integrates Cercare Medical Neurosuite (CMN), a vendor-neutral imaging platform that provides automated perfusion analysis across CT, MRI, and Cone-Beam CT, with Siemens Healthineers’ Syngo DynaCT Multiphase system.

The solution integrates Syngo.CT Coronary Cockpit on the Syngo.via platform with Syngo PCI Connect running on Artis angiography systems.

The company will present its newly CE-marked AI contouring solution at the annual congress of the European Society for Radiotherapy and Oncology in Stockholm.